No Specific Antiviral Medications Are Recommended for Acute Hepatitis A Infection
Acute hepatitis A infection requires only supportive care, as there are no proven effective antiviral therapies for this condition. 1
Treatment Approach
Supportive Care Only
Patients with acute hepatitis A should receive:
- Supportive care with no restrictions in diet or activity 1
- Hospitalization only if dehydration occurs from severe nausea and vomiting 1
- Critical hospitalization for any signs of acute liver failure 1
Medications to Avoid
Avoid hepatotoxic medications and substances:
- Acetaminophen (due to hepatotoxic potential) 1
- Alcohol consumption 1
- Any medications metabolized by the liver should be used with extreme caution 1
When to Escalate Care
Immediate referral to a liver transplant center is indicated if:
- INR >1.5 develops
- Any signs of acute liver failure appear (hepatic encephalopathy)
- Progressive liver synthetic dysfunction occurs
While acute liver failure from hepatitis A is rare, it represents a life-threatening complication requiring specialist management 1.
Investigational Approaches
Recent research has identified potential antiviral candidates (such as hepato-selective dihydroquinolizinones) that show promise in preclinical studies 2, but none are currently approved or available for clinical use. Corticosteroids have been suggested for prolonged cholestatic hepatitis in some case reports 3, but this remains investigational without strong evidence.
Prevention Focus
Since no effective treatment exists, prevention through vaccination remains the most effective strategy 1. The hepatitis A vaccine provides long-lasting immunity and should be prioritized for at-risk populations including MSM, injection drug users, and persons with chronic liver disease 1.
The clinical course is typically self-limited, with most patients recovering within 3-4 weeks without specific antiviral intervention 4.